Venture NAV Tracker / Private company
Candel Therapeutics, Inc.
Headquarters—
Founded—
Last known round—
Reported valuation—
Cross-fund comparison
Equity & warrant marks
One latest disclosed mark per fund.
| Fund | Fair value | Security / basis | Implied price / share | Mark age vs round | Methodology / filing |
|---|---|---|---|---|---|
| TRINTrinity Capital Inc. | $1MMar 31, 2026 · source ↗ | warrantFair Value | $4.67Mar 31, 2026 · source ↗ | —Mar 31, 2026 · source ↗ | 10-Q 2026-03-31 ↗ |
Cross-fund comparison
Debt investments
One latest disclosed debt mark per fund.
| Fund | Security type / basis | Principal | Fair value | FV / principal | Rate | Maturity | Mark age vs round | Non-accrual |
|---|---|---|---|---|---|---|---|---|
| TRINTrinity Capital Inc. | senior secured loanFair Value — Secured Loan | $43.5MMar 31, 2026 · source ↗ | $42.5MMar 31, 2026 · source ↗ | 97.8%Mar 31, 2026 · source ↗ | Variable interest rate Prime + 3.0% or Floor rate 9.8%; EOT 4.3%Mar 31, 2026 · source ↗ | Oct 1, 2030Mar 31, 2026 · source ↗ | —Mar 31, 2026 · source ↗ | NoMar 31, 2026 · source ↗ |
Historical marks
Reported fair value by fund
Each bar is a disclosed position-quarter.